Eye Chart Pro is a clinically-reviewed, randomizable visual acuity exam tool for eye care professionals on iPad.
The App DNA
What makes this app unique?
It removes the patient memorization bias inherent in static wall charts, providing a more accurate vision screen for house visits and triaging.
For Eye care professionals and clinicians requiring portable, randomized visual acuity testing tools for triaging or house visits.
Key features
Generates randomized eye charts to prevent patient memorization, establishing category authority via clinical validation.
Allows providers to control the chart display on a secondary device, acting as a retention lever for clinical efficiency.
Switches measurement units between metric and feet for global clinical compatibility.
How much does it cost?
The app operates as a free tool with no visible monetization, positioning itself as a clinical resource to build professional reputation.
Velocity
Dormant developmentopaqueShow more...
The app has not received a feature update or maintenance patch in 600 days. Development momentum is non-existent, with no activity recorded in the provided history. The project appears to be in a dormant state.
Who built it?
Dok
4 apps tracked · Medical
Eye Chart Pro Remote Control
EyeChart - Vision Screening
Eye Chart HDUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Eye Chart Pro
How's the Medical market?
Eye Chart Pro maintains a niche position as a clinically-validated, free medical utility for eye care professionals. The 600-day update gap signals a maintenance-mode posture that risks losing ground to active competitors in the portable diagnostic space.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Eye Chart Pro
Where is it heading?
The portable diagnostic market is shifting toward integrated, multi-functional clinical suites that offer more than just static chart generation. Eye Chart Pro remains exposed due to its long-term development silence, which will likely lead to churn as professional users migrate to tools with more active support cycles.
- The 600-day update gap suggests a maintenance-only posture, which erodes professional trust as clinicians require tools that keep pace with hardware updates.
The SWOT
- Peer-reviewed clinical validation establishes a defensible authority barrier.
- Remote control functionality increases clinical efficiency during exams.
- Localized pricing or premium clinical features could monetize the existing professional user base.
Next best moves
Audit current codebase for compatibility with latest iPadOS because the 600-day update gap risks app instability → maintain clinical trust
The counter-intuitive read
The 600-day update gap is not necessarily a failure…
Read the full takeBottom line
Eye Chart Pro rests on a foundation of peer-reviewed clinical validation that competitors lack. The current 600-day update gap risks eroding this professional trust, as clinicians prioritize tools with active maintenance and modern device support.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated